Comment in

• Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk pulmonary embolism secondary to a major transient/reversible risk factor?

  Slabbynck H, Clukers J, Galdermans D. Slabbynck H, et al. Eur Respir J. 2020 Jan 30;55(1):1902028. doi: 10.1183/13993003.02028-2019. Print 2020 Jan. Eur Respir J. 2020. PMID: 32001499 No abstract available.
• Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk pulmonary embolism secondary to a major transient/reversible risk factor?

  Meyer G, Konstantinides S. Meyer G, et al. Eur Respir J. 2020 Jan 30;55(1):1902323. doi: 10.1183/13993003.02323-2019. Print 2020 Jan. Eur Respir J. 2020. PMID: 32001500 No abstract available.
• Chronic thromboembolic disease following pulmonary embolism: time for a fresh look at old clot.

  McCabe C, Dimopoulos K, Pitcher A, Orchard E, Price LC, Kempny A, Wort SJ. McCabe C, et al. Eur Respir J. 2020 Apr 3;55(4):1901934. doi: 10.1183/13993003.01934-2019. Print 2020 Apr. Eur Respir J. 2020. PMID: 32245771 No abstract available.
• Chronic thromboembolic disease following pulmonary embolism: more work ahead.

  Konstantinides SV. Konstantinides SV. Eur Respir J. 2020 Apr 3;55(4):2000229. doi: 10.1183/13993003.00229-2020. Print 2020 Apr. Eur Respir J. 2020. PMID: 32245774 No abstract available.
• Ventilation-perfusion SPECT versus CTPA in young adult females with suspected pulmonary embolism.

  Hansen SL, de Nijs R, Mortensen J, Berg RMG. Hansen SL, et al. Eur Respir J. 2020 Jun 11;55(6):2000448. doi: 10.1183/13993003.00448-2020. Print 2020 Jun. Eur Respir J. 2020. PMID: 32527852 No abstract available.
• The optimal imaging test for diagnosis of acute pulmonary embolism: a second chance for lung scintigraphy?

  Konstantinides SV. Konstantinides SV. Eur Respir J. 2020 Jun 11;55(6):2001426. doi: 10.1183/13993003.01426-2020. Print 2020 Jun. Eur Respir J. 2020. PMID: 32527854 No abstract available.